TransMedics Group Reaches Analyst Target Price
In recent trading, shares of TransMedics Group Inc (Symbol: TMDX) have crossed above the average analyst 12-month target price of $94.36, changing hands for $94.77/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade o
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- Grupo Cibest Reaches Analyst Target Price nasdaq.com
